Felip E, Rojas CI, Schenker M, Kowalski DM, et al. Subcutaneous Versus Intravenous Pembrolizumab, in Combination With Chemotherapy, for Treatment of Metastatic Non-Small Cell Lung Cancer: The Phase 3 3475A-D77 Trial. Ann Oncol 2025 Mar 25:S0923-7534(25)00123-1. doi: 10.1016/j.annonc.2025.
PMID: 40157574